The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Bronze - Individuals: litigation
Proficiency in life sciences patent litigation is a defining feature of Goodwin Procter’s IP practice; it has tremendous depth in the area and both seasoned and fast-rising stars on its roster. Well on her way to senior leadership is Huiya Wu, who has clocked up more than 20 years of experience. “She does a fantastic job leading on matters from inception through trial and is smart, experienced and well versed in managing complex pharmaceutical litigations. She has become a go-to for biosimilar matters.” Turning heads as an up and comer, Alexandra Valenti also garners excellent references: “Alex thoroughly understands the development history of complex biologics products and the context of disputes. She demonstrates mastery of the facts of her cases and delivers successful strategies, while running everything to the highest professional standards. She is extremely polished and a superb litigator.” Entering the IAM Patent 1000 for the first time this year, Linnea Cipriano is also gaining momentum thanks to sterling performances in district courts and the PTAB. With Wu, she is currently acting for Amneal Pharmaceuticals in a Hatch-Waxman litigation against patentee Par Pharmaceutical, which sells injectable blood pressure treatment Vasostrict, for which there is currently no generic version. Goodwin Procter also has talent up and down the ranks on the high-technology side, where it litigates with equal proficiency. The names to know in this regard are Mark Abate and Naomi Birbach, who have teamed up to defend Pass & Seymour in a dispute with Leviton Manufacturing, another leading company in the ground fault circuit interrupters market. Abate is well known for his representation of IBM, for which he has racked up many victories. Elevated to partner in 2021, Birbach is doing important work for household-name companies such as Facebook, for which she recently obtained a dismissal of a multi-patent case on Section 101 grounds.